According to the literature, the increase of IL-17A was observed in autoimmune diseases such as rheumatoid arthritis, multiple sclerosis, systemic lupus erythematosus, and inflammatory bowel disease [9, 12, 32]. This evidence concerns the gene IL17A and systemic lupus erythematosus.